reglab/statecodes huggingface dataset:
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-89 - Chlamydial infections, genital; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 89.
The specific control measures for chlamydial infections,
				  genital (infectious agent: Chlamydia trachomatis) (see psittacosis for
				  infections caused by Chlamydia psittaci) are as follows:
(1) An investigation by the local health
				officer shall be:
(A) performed within
				seventy-two (72) hours; and
(B)
				focused on identifying sexual partners who were at risk for transmitting to, or
				contracting the infection from, the case.
Case and contacts shall be fully evaluated and treated as
				  recommended in the Sexually Transmitted Diseases Treatment Guidelines, 2010,
				  Morbidity and Mortality Weekly Report, December 17, 2010, Volume 59, No. RR-12.
				  Expedited partner therapy is allowed for the treatment of sex partners for
				  chlamydia (http://www.in.gov/isdh/files/EPT_Guidance_Document.pdf).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-90 - Cholera; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 90.
The specific control measures for cholera (infectious agent:
				  Vibrio cholerae 01 or 0139) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a five (5) day history of the
				following prior to symptom onset:
(i) Food and
				drink consumption.
(ii) Water
				exposure.
(iii) Domestic and
				international travel.
(C) Determine if the case is part of an
				outbreak.
(D) Determine if the case
				is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) Interview individuals who consumed food
				and water with the patient to identify additional cases and determine the
				contaminated food or water source. If suspicion centers on water, a commercial
				food product, or a restaurant as a potential source, active surveillance shall
				be carried out to identify additional cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-91 - Coccidioidomycosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 91.
The specific control measures for coccidioidomycosis
				  (infectious agent: Coccidioides immitus and posadasi or Coccidioides species)
				  are as follows:
(1) An investigation
				by the local health officer shall be performed within seventy-two (72)
				hours.
(2) Standard precautions are
				required for hospitalized patients.
(3) Concurrent disinfection is
				required.
(4) Quarantine is not
				required.
(5) Immunization is not
				available. Protection of contacts is not applicable.
(6) The Centers for Disease Control and
				Prevention and the Council of State and Territorial Epidemiologists set the
				standard clinical and laboratory case definition.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-92 - Cryptosporidiosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 92.
The specific control measures for cryptosporidiosis
				  (infectious agent: Cryptosporidium species) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a seven (7) day
				food and exposure history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Daycare or preschool children.
(iii) Animal exposures.
(iv) Surface water.
(C) Determine if the case is part of an
				outbreak.
(D) Determine if the case
				is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) If suspicion centers on a commercial food
				product, restaurant, recreational water setting, or public water supply, active
				surveillance shall be instituted to identify additional cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-93 - Cyclosporiasis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 93.
The specific control measures for cyclosporiasis (infectious
				  agent: Cyclospora cayetanensis) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a seven (7) day
				history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Domestic and international
				travel.
(iii) Water
				exposures.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) If a commercial food source is suspected,
				active surveillance shall be undertaken. Direct person-to-person transmission
				is unlikely, so focus should be on a water or food source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-94 - Cysticercosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 94.
The specific control measures for cysticercosis (infectious
				  agent: Taenia solium) are as follows:
(1) An investigation by the local health
				officer shall:
(A) be performed within
				seventy-two (72) hours; and
(B)
				focus on source of exposure to:
(i) travel
				history (lifetime); and
(ii)
				identify and interview family members and household contacts to identify
				additional cases of cysticercosis or taeniasis (infection with Taenia
				solium).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-95 - Diphtheria; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 95.
The specific control measures for diphtheria (infectious
				  agent: Corynebacterium diphtheriae) are as follows:
(1) An investigation by a department field
				representative, in cooperation with the local health officer, shall:
(A) be performed immediately; and
(B) include case management of diphtheria.
The investigation shall include, at a minimum, determination
				  of immunization status of the index case or suspect case. Culture shall be
				  obtained for organism identification. A complete list of contacts shall be
				  generated. Contacts are defined as all individuals in the household, all
				  individuals with a history of habitual, close contact, and all individuals
				  directly exposed to throat and nasal secretions of the patient.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-96 - Ehrlichiosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 96.
The specific control measures for ehrlichiosis (infectious
				  agent: Ehrlichiaor Anaplasma species) are as follows:
(1) An investigation by the local health
				officer shall:
(A) be performed within
				seventy-two (72) hours; and
(B)
				include an interview with the patient to determine:
(i) exposure to ticks; and
(ii) the location of exposure for the
				previous four (4) weeks.
Information gathered is useful in identifying foci of
				  infected environments and public education campaigns on prevention.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-97 - Escherichia coli infection (Shiga toxin-producing): E. coli 0157, E. coli 0157:H7, non-0157 E. coli, and Shiga toxin detected and hemolytic uremic syndrome (HUS), postdiarrheal; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 97.
The specific control measures for Escherichia coli (E. coli)
				  infection (Shiga toxin-producing (STEC)), including, but not limited to, E.
				  coli 0157, E. coli 0157:H7, non-0157 E. coli, and Shiga toxin detected and
				  hemolytic uremic syndrome (HUS) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a seven (7) day history of the
				following prior to symptom onset:
(i) Food and
				drink consumption.
(ii) Water
				exposures.
(iii) Animal
				exposures.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) Determine if the case is a contact of a
				food employee serving a highly susceptible population.
(F) Determine if meal companions are
				additional cases.
(G) If a
				commercial food product or restaurant is suspected, conduct active surveillance
				for additional cases. Medical evaluation, including adequate laboratory
				examination of feces of contacts, should be limited to food employees, daycare
				workers, health care workers, or other situations where outbreaks may
				occur.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-98 - Giardiasis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 98.
The specific control measures for giardiasis (infectious
				  agent: Giardia species) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a seven (7) day
				history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Contact with daycare or preschool
				children.
(iii) Animal
				exposures.
(iv) Surface
				water.
(v) Recreational water
				setting.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) If suspicion centers on a commercial food
				product, restaurant, or public water supply, active surveillance shall be
				instituted to identify additional cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-99 - Gonorrhea; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 99.
The specific control measures for gonorrhea (infectious
				  agent: Neisseria gonorrhoeae) are as follows:
(1) An investigation by the local health
				officer shall be:
(A) performed within
				seventy-two (72) hours; and
(B)
				focused on identifying sexual partners who were at risk for transmitting to, or
				contracting the infection from, the case.
Case and contacts shall be fully evaluated and treated as
				  recommended in the Update to CDC's Sexually Transmitted Diseases Treatment
				  Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for
				  Gonococcal Infections, 2012, Morbidity and Mortality Weekly Report; August 10,
				  2012; Vol. 61; No. 31. Expedited partner therapy is allowed for the treatment
				  of sex partners for gonorrhea
				  (http://www.in.gov/isdh/files/EPT_Guidance_Document.pdf).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-100 - Granuloma inguinale; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 100.
The specific control measures for granuloma inguinale
				  (infectious agent: Calymmatobacterium granulomatis) are as follows:
(1) An investigation by the local health
				officer shall be:
(A) performed within
				seventy-two (72) hours; and
(B)
				focused on identifying sexual partners who were at risk for transmitting to, or
				contracting the infection from, the case.
Case and contacts shall be fully evaluated and treated as
				  recommended in the Sexually Transmitted Diseases Treatment Guidelines, 2010,
				  Morbidity and Mortality Weekly Report, December 17, 2010, Volume 59, No.
				  RR-12.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-101 - Haemophilus influenzae invasive disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 101.
The specific control measures for Haemophilus influenzae
				  type B (Hib) invasive disease (infectious agent: Haemophilus influenzae) are as
				  follows:
(1) An investigation by a
				department field representative, in cooperation with the local health officer,
				shall:
(A) be performed within twenty-four
				(24) hours; and
(B) include:
(i) case management;
(ii) an immunization history of the index
				case; and
(iii) identification of
				all contacts less than four (4) years of age.
Contacts are defined as household contacts or individuals who
				  spent four (4) or more hours with the index case for at least five (5) of the
				  seven (7) days preceding the day of hospital admission of the case.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-102 - Hansen's disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC 16-41-2
Affected: IC 16-41-2; IC 16-41-9
Sec. 102.
The specific control measures for Hansen's disease
				  (infectious agent: Mycobacterium leprae) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Ensure household
				contacts who have resided with the patient up to three (3) years prior to
				lesion onset are examined initially, and provide education on the necessity of
				obtaining physical exams annually for the next five (5) years following the
				last contact with an infectious patient.
(C) Routine prophylaxis of contacts is not
				recommended.
(D) Direct observation
				therapy of multidrug therapy shall be used to ensure compliance with the
				medical regime for active cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-103 - Hantavirus; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC 16-41-2
Affected: IC 16-41-2; IC 16-41-9
Sec. 103.
The specific control measures for hantavirus (infectious
				  agent: hantavirus including Sin Nombre virus) are as follows:
(1) An investigation by the local health
				officer shall:
(A) be performed
				immediately;
(B) include:
(i) case ascertainment; and
(ii) identification of the source of
				infection; and
(C)
				identify the source of exposure to rodent feces and urine.
Exterminate rodents at suspected site of infection and
				  disinfect environmental surfaces.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-104 - Hepatitis, viral, type A; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 104.
The specific control measures for hepatitis, viral, type A
				  (infectious agent: hepatitis A virus) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a history of the following prior
				to symptom onset:
(i) Food and drink
				consumption.
(ii) Exposure to
				undercooked food items.
(iii)
				Domestic and international travel.
(iv) Sexual exposure during the fifteen (15)
				to fifty (50) day period prior to the onset of illness.
(C) Determine if the case is part of an
				outbreak.
(D) Determine if the case
				is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) Determine if the case is a contact of a
				food employee serving a highly susceptible population.
(F) If a commercial food product or
				restaurant is suspected, the local health officer shall initiate active
				surveillance immediately to identify additional cases.
(G) Determine the infectious period, which is
				defined as from seven (7) days before to fourteen (14) days after the onset of
				symptoms if no jaundice occurred; otherwise, the infectious period is defined
				as from fourteen (14) days prior to seven (7) days after the onset of
				jaundice.
(H) Prepare a list of all
				contacts during the infectious period and work schedules or school attendance
				records, or both, during the infectious period.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-105 - Hepatitis, viral, type B and type D; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-7; IC 16-41-9
Sec. 105.
The specific control measures for hepatitis, viral, type B
				  (infectious agent: hepatitis B virus) and type D (infectious agent: delta
				  hepatitis, occurs only in individuals with acute or chronic hepatitis B virus
				  infection) are as follows:
(1) An
				investigation and case management duties are assigned as follows:
(A) An investigation and case management of
				infants born to HBsAg (+) pregnant women shall:
(i) begin immediately (when infection is
				identified at or close to the time of birth); and
(ii) be performed by a department
				representative in cooperation with the local health officer; for the purpose of
				ensuring that infants receive hepatitis B immune globulin and the complete HBV
				vaccine series.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-106 - Hepatitis C infection; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 106.
The specific control measures for hepatitis C (acute)
				  (infectious agent: hepatitis C virus) are as follows:
(1) An investigation by the local health
				officer shall be performed within five (5) business days for the purpose of
				determining risk factors for infection and obtaining contacts. Contacts are
				defined as sexual partners, household members, individuals with whom needles
				have been shared, and others who have been exposed to infectious body fluids.
				In addition, the investigation shall focus on a history of the following:
(A) Surgery.
(B) Transfusion or other blood products
				exposures.
(C)
				Hemodialysis.
(D) Employment as a
				health care worker.
(E) Other
				contacts with blood or other potentially infectious materials during the
				incubation period.
When two (2) or more cases occur in association with some
				  common exposure, a search for additional cases shall be conducted. If
				  transfused blood or blood products is implicated in the transmission, the lot
				  shall be withdrawn from use and reasonable steps taken to ensure that no
				  further donations from the infected donor are utilized.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-107 - Hepatitis E infection; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 107.
The specific control measures for hepatitis, viral, type E
				  (infectious agent: hepatitis E virus) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a history of the following
				fifteen (15) to sixty-four (64) days prior to symptom onset:
(i) Food and drink consumption.
(ii) Exposure to undercooked food
				items.
(iii) Domestic and
				international travel.
(iv) Surface
				water.
(v) Animal
				exposures.
(vi) Sexual
				exposure.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) If a commercial food product or
				restaurant is suspected, conduct active surveillance immediately to identify
				additional cases.
(F) Determine the
				infectious period, which is defined as from seven (7) days before to fourteen
				(14) days after the onset of jaundice or from the onset of symptoms if no
				jaundice occurred.
(G) Prepare a
				list of contacts and work schedules or school attendance records, or both,
				during the infectious period.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-108 - Histoplasma capsulatum; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 108.
The specific control measures for Histoplasma capsulatum
				  (infectious agent: Histoplasma capsulatum) are as follows:
(1) An investigation by the local health
				officer shall:
(A) be performed within
				seventy-two (72) hours;
(B)
				determine potential sources of exposure; and
(C) evaluate the potential for occupational
				exposure and, in the event of two (2) or more cases, for evidence of infection
				from a common environmental source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-109 - Human immunodeficiency virus infection/disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41
Sec. 109.
The specific control measures for HIV are as follows:
(1) An investigation by a disease
				intervention specialist shall:
(A) be
				performed within seventy-two (72) hours; and
(B) include partner services.
Persons who are tested anonymously at counseling and testing
				  sites cannot be reported using personal identifiers. Rather, they are to be
				  reported using a numeric identifier code. Age, race, sex, risk factors, and
				  county of residence shall also be reported. HIV infected persons are required
				  to warn contacts of their disease status and the need to seek health care, such
				  as counseling and testing. All identified contacts should receive counseling
				  and be offered serologic testing. Until their status with regard to infection
				  has been determined, contacts shall refrain from sexual activities involving
				  the exchange of body fluids. All contacts shall not share needles and syringes
				  with other persons without first notifying the other persons of their disease
				  status.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-110 - Influenza-associated death; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 110.
The specific measures for influenza-associated deaths are as
				  follows:
(1) An investigation by the
				local health officer shall:
(A) be performed
				within seventy-two (72) hours; and
(B) include:
(i) influenza testing;
(ii) an influenza vaccination
				history;
(iii) a history of disease
				and resultant complications; and
(iv) an epidemiologic
				investigation.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-111 - Latent tuberculosis infection; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 111.
The specific control measures for latent tuberculosis
				  infection (LTBI) (infectious agent: Mycobacterium tuberculosis) are as
				  follows:
(1) All newly diagnosed cases
				of LTBI shall be reported to the local health officer or the department within
				five (5) business days.
(2) The
				clinician providing medical oversight to diagnosed cases of LTBI with a
				multiple drug-resistant source case are required to consult with the local
				health officer or the department for treatment options and length of
				treatment.
(3) The local health
				officer shall perform an investigation on all newly diagnosed cases of LTBI
				requesting the following:
(A) Tuberculosis
				screening test results of either a tuberculosis skin test (TST) using a
				purified protein derivate (PPD) or an interferon gamma release assay (IGRA) of
				blood.
(B) Radiological
				studies.
(C) Other studies or
				laboratory tests needed to ascertain the absence of tuberculosis
				disease.
(D) Risk factors for
				progression to active tuberculosis disease.
(E) HIV status.
(F) Country of birth.
(G) Treatment regimen.
(H) Start of treatment date.
This information shall be reported to the department by the
				  health officer in a timely manner.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-112 - Legionellosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 112.
The specific control measures for legionellosis (infectious
				  agent: Legionella species) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours in the event that:
(A) a single nosocomial case is identified;
				or
(B) two (2) or more cases that
				are not nosocomial cases are identified.
A definite nosocomial case is a laboratory confirmed case who
				  has spent ten (10) days or more continuously and admitted to a health care
				  facility. A possible nosocomial case is a laboratory case that occurs two (2)
				  to nine (9) days after discharge from a health care facility. The investigation
				  shall focus on environmental sources for the exposure in the health care
				  facility for nosocomial cases or places of common exposure for those infections
				  not associated with a health care facility. Environmental laboratory results
				  shall be provided to the health department immediately once a single nosocomial
				  case or two (2) or more non-nosocomial cases are detected. Active surveillance
				  for additional cases shall be undertaken.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-113 - Leptospirosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 113.
The specific control measures for leptospirosis (infectious
				  agent: Leptospira species) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours:
(A) for case ascertainment; and
(B) to identify potential sources of the
				infection, such as contaminated water or occupational exposure, including
				handling of infected animals.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-114 - Listeriosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 114.
The specific control measures for listeriosis (infectious
				  agent: Listeria monocytogenes) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a twenty-one
				(21) day history of the following prior to onset:
(i) Food and drink consumption.
(ii) Exposure to soil.
(iii) Animal exposures.
The food history should include a history of consuming raw
				  milk, soft cheese, raw vegetables, and ready-to-eat meats. Surveillance data
				  should be analyzed for clusters and clusters for common source
				  exposures.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-115 - Lyme disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 115.
The specific control measures for Lyme disease (infectious
				  agent: Borrelia burgdorferi) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours to:
(A) determine the location of exposure to
				ticks; and
(B) identify
				tick-infested areas.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-116 - Lymphogranuloma venereum; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 116.
The specific control measures for lymphogranuloma venereum
				  (infectious agent: Chlamydia trachomatis) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours. Partner services
				shall be provided by a disease intervention specialist.
(2) Standard precautions for hospitalized
				patients are required. Cases shall refrain from sexual contact until lesions
				are healed.
(3) Careful disposal of
				articles:
(A) contaminated with discharges
				from lesions; or
(B) soiled by
				discharges; is required.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-117 - Malaria; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 117.
The specific control measures for malaria (infectious
				  agents: Plasmodium species) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours to determine the
				history of previous infection or possible exposure. The travel history shall be
				evaluated to determine if the case is from foreign travel or local exposure.
				Exposure may occur:
(A) from exposure to
				infected mosquitoes;
(B) from
				transfusions with infected blood; or
(C) through needle sharing.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-119 - Meningococcal invasive disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 119.
The specific control measures for meningococcal invasive
				  disease (infectious agent: Neisseria meningitidis) are as follows:
(1) An investigation shall be performed
				immediately upon suspicion of a case by the local health officer or designee
				for the purpose of identifying and treating close contacts as follows:
(A) Close contacts are defined as the
				following:
(i) Daycare or preschool contact at
				any time during seven (7) days before onset of symptoms.
(ii) Individuals who have shared residence
				with the patient.
(iii) Direct
				exposure to patient's saliva during seven (7) days prior to onset of
				symptoms.
(iv) Passengers seated
				directly next to the patient during airline flights lasting more than eight (8)
				hours.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-120 - Mumps; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 120.
The specific control measures for mumps (infectious agent:
				  mumps virus) are as follows:
(1) An
				investigation by a department field representative in cooperation with the
				local health officer shall meet the following conditions:
(A) Be performed within twenty-four (24)
				hours.
(B) Include:
(i) obtaining clinical specimens in suspect
				cases; and
(ii) identifying
				susceptible contacts who should be immunized. Contacts are defined as any
				individual who had unprotected face-to-face (less than three (3) feet) contact
				with the suspect case for at least five (5) minutes during the infectious
				period. The infectious period is defined as two (2) days before swelling onset
				until five (5) days after swelling onset.
(C) Acceptable proof of immunity shall
				consist of a:
(i) written record from the
				student's or employee's physician, parent, or guardian that indicates the dates
				of vaccination (on or after the first birthday) and the type of vaccine
				administered;
(ii) laboratory
				report showing confirmation of previous mumps infection; or
(iii) laboratory report showing a protective
				mumps antibody titer.
(D) For outbreak control, exclude exposed
				contacts born in or after 1957 without proof of immunity from school or the
				workplace from the ninth day to the twenty-fifth day after exposure. Excluded
				workers and students can immediately return to work or school after they are
				vaccinated.
(E) For outbreak
				control in health care facilities, all health care workers and employees,
				regardless of age, without evidence of immunity who have been exposed to mumps
				should be excluded from the facility from the ninth day to the twenty-fifth day
				after exposure, even if postexposure vaccination was administered.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-121 - Novel influenza A; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 121.
The specific control measures for novel influenza A
				  (infectious agent: novel influenza A virus) are as follows:
(1) An investigation by the local health
				officer shall be performed within twenty-four (24) hours.
(2) Standard precautions are required for
				hospitalized patients. Respiratory protection that is at least as protective as
				a fit-tested N95 respirator for health care personnel who are in close contact
				with patients with suspect or confirmed novel influenza A is recommended. This
				recommendation may change after there has been adequate time to assess the
				recommendation, and the Centers for Disease Control and Prevention will
				continue to revisit its guidance as new information and sufficient supplies
				become available.
(3) Concurrent
				disinfection is required.
(4)
				Quarantine is not required.
(5)
				Immunization is not available. Protection of contacts is not
				applicable.
(6) The Centers for
				Disease Control and Prevention and the Council of State and Territorial
				Epidemiologists set the standard clinical and laboratory case
				definition.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-122 - Pertussis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 122.
The specific control measures for pertussis (infectious
				  agent: Bordetella pertussis) are as follows:
(1) An investigation by a department field
				representative, in cooperation with the local health officer, shall be
				performed within twenty-four (24) hours for the purpose of case ascertainment
				and identification of close contacts. Close contacts are defined as household
				and daycare or preschool contacts and persons who have had direct contact with
				respiratory secretions of the case, including, but not limited to, the
				following:
(A) Explosive cough or sneeze in
				the face.
(B) Sharing food or
				utensils.
(C) Kissing.
(D) Mouth to mouth resuscitation.
(E) Performing a full medical exam, including
				examination of the nose and throat.
A search for unrecognized or unreported, early, and atypical
				  cases is indicated where a nonimmune infant or child is, or might be, at
				  risk.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-123 - Plague; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 123.
The specific control measures for plague (infectious agent:
				  Yersinia pestis) are as follows:
(1)
				An investigation by the local health officer shall be performed immediately to
				identify all contacts. Contacts are defined as those individuals who have been
				in household or face-to-face contact with patients with pneumonic plague.
				Establish if the case had traveled to endemic areas in the past seven (7) days.
				Determine if patients:
(A) were exposed to
				rodents, cats, or dogs; or
(B)
				visited areas of rodent habitat during travel.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-124 - Poliomyelitis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 124.
The specific control measures for poliomyelitis (infectious
				  agent: poliovirus) are as follows:
(1)
				An investigation by a department field representative, in cooperation with the
				local health officer, shall be performed immediately and include the following:
(A) Laboratory confirmation.
(B) The immunization status of the
				case.
(C) The time since the last
				vaccination.
(D) The type of
				vaccine given.
(E) A history of
				underlying immunosuppressive condition.
(F) A history of contact with high risk
				individuals, such as the following:
(i)
				Persons who object to vaccination.
(ii) Recent immigrants.
(iii) Travelers.
(iv) Persons who are a probable or confirmed
				case of polio.
A travel history of the case shall be determined. If wild
				  poliovirus is implicated, an immunization program designed to contain the
				  spread shall be initiated using trivalent polio vaccine. A thorough search
				  shall be conducted for sick persons, especially children, to ensure early
				  detection, facilitate control, and permit appropriate treatment of unrecognized
				  and unreported cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-125 - Psittacosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 125.
The specific control measures for psittacosis (infectious
				  agent: Chlamydophila psittaci) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include:
(i) identifying the source of infection;
				and
(ii) implementation of control
				measures.
(C) Identify
				exposure to:
(i) psittacine birds (owned by
				individuals or pet shops);
(ii)
				occupational exposure to poultry flocks; or
(iii) processing plants; for the previous
				four (4) weeks.
Identified locations for potential exposure shall be
				  forwarded to the Indiana state board of animal health for investigation.
(2)  Standard
				precautions are required. Coughing patients shall cough into tissue to prevent
				aerosolization of infectious agent.
(3) Concurrent disinfection is required for
				all discharges.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-126 - Q fever; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC
				  16-41-2-1
Sec. 126.
The specific control measures for Q fever (infectious agent:
				  Coxiella burnetii) are as follows:
(1)
				An investigation by the local health officer shall be performed immediately for
				case ascertainment and identification of an infection source. Investigation of
				the infection source shall be directed at:
(A)
				exposure to sheep, cattle, and goats;
(B) consumption of unpasteurized milk;
				and
(C) laboratories that handle
				the disease agents.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-127 - Rabies, human and animal; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 15-2.1-6-11; IC 16-41-2; IC 16-41-9
Sec. 127.
The specific control measures for rabies (see also animal
				  bites in section 80 of this rule) are as follows:
(1) An investigation by the local health
				officer in collaboration with the state public health veterinarian shall:
(A) be performed immediately; and
(B) identify:
(i) the route of the exposure;
(ii) the animal responsible for the exposure;
				and
(iii) other individuals who may
				have been exposed to:
(AA) that animal;
				or
(BB) the salivary secretions of
				the patient.
Individuals who have been exposed to salivary secretions of
				  the patient shall be evaluated for postexposure prophylaxis. Postexposure
				  prophylaxis guidance is provided in section 80 of this rule.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-128 - Rocky Mountain spotted fever; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 128.
The specific control measures for Rocky Mountain spotted
				  fever (infectious agent: Rickettsia rickettsii) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours to determine the
				location of exposure to infected ticks. Recent travel and exposure to
				tick-infested areas shall be identified.
(2) Standard precautions are required for
				hospitalized patients.
(3)
				Concurrent disinfection is required. All ticks shall be removed from the
				patient.
(4) Quarantine is not
				required.
(5) Immunization is not
				available. Protection of contacts is not applicable.
(6) The Centers for Disease Control and
				Prevention and the Council of State and Territorial Epidemiologists set the
				standard clinical and laboratory case definition.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-129 - Rubella (German measles); specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 129.
The specific control measures for rubella (German measles)
				  (infectious agent: rubella virus) are as follows:
(1) An investigation by a department field
				representative in cooperation with the local health officer shall be performed
				immediately and include case management, case ascertainment, previous
				immunization history, and identification of exposed pregnant female and other
				susceptible contacts. For outbreak control in public or private schools,
				daycare facilities, preschools, or postsecondary facilities, on the same day
				that a report of a suspected case of rubella is received, school personnel
				shall do the following:
(A) Conduct an inquiry
				into absenteeism to determine the existence of any other cases of the
				illness.
(B) Immediately report the
				suspect case or cases to the local health department or the
				department.
(C) Send a notice home
				with each student, attendee, or employee born in or after 1957 who has not
				presented proof of immunity, explaining that the student or employee shall be
				excluded from a given day until acceptable proof of immunity is received by the
				school or, in the case of medical or religious exemptions, until twenty-three
				(23) days after the onset of the last reported rubella case. Acceptable proof
				shall consist of one (1) or more of the following:
(i) A written record from the student's
				physician or parent or guardian that indicates the:
(AA) date of vaccination (on or after the
				first birthday); and
(BB) type of
				vaccine administered.
(ii) A laboratory report showing a protective
				rubella antibody titer.
(iii) A
				laboratory report showing confirmation of previous rubella infection.
(D) Make available to officials of
				the local health department or the department, or both, involved in
				investigating and controlling the outbreak, immunization records of all
				students and employees born in or after 1957 in the school or postsecondary
				facility or attendees and employees born in or after 1957 in daycare or
				preschool.